Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Brand

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Pharmacogenetics and Genomics|July 12, 2007
Neutrophil elastase gene variation and coronary heart diseaseJacqueline Schönfelder, Ralph Telgmann, Viviane Nicaud, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2017
Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosagesJohannes Krämer, Malte Lenders, Sima Canaan-Kühl, et al.
Journal of Hypertension|January 15, 2008
SAH gene variants revisited in the European Project On Genes in HypertensionValérie Tikhonoff, Jan A Staessen, Tatiana Kuznetsova, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
Journal of Hypertension|August 13, 2002
Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian populationElisabeth J Balkestein, Ji Guang Wang, Harry A J Struijker-Boudier, et al.
Molecular Genetics & Genomic Medicine|April 13, 2018
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry studyDominique P Germain, Eva Brand, Alessandro Burlina, et al.
Circulation|October 20, 2004
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretionTatiana Kuznetsova, Jan A Staessen, Lutgarde Thijs, et al.
International Journal of Molecular Sciences|August 19, 2020
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry DiseaseSanne J van der Veen, Wytze J Vlietstra, Laura van Dussen, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2004
Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretionKatarzyna Stolarz, Jan A Staessen, Kalina Kawecka-Jaszcz, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2014
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switchFrank Weidemann, Johannes Krämer, Thomas Duning, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Pharmacogenetics and Genomics|July 12, 2007
Neutrophil elastase gene variation and coronary heart diseaseJacqueline Schönfelder, Ralph Telgmann, Viviane Nicaud, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2017
Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosagesJohannes Krämer, Malte Lenders, Sima Canaan-Kühl, et al.
Journal of Hypertension|January 15, 2008
SAH gene variants revisited in the European Project On Genes in HypertensionValérie Tikhonoff, Jan A Staessen, Tatiana Kuznetsova, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
Journal of Hypertension|August 13, 2002
Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian populationElisabeth J Balkestein, Ji Guang Wang, Harry A J Struijker-Boudier, et al.
Molecular Genetics & Genomic Medicine|April 13, 2018
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry studyDominique P Germain, Eva Brand, Alessandro Burlina, et al.
Circulation|October 20, 2004
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretionTatiana Kuznetsova, Jan A Staessen, Lutgarde Thijs, et al.
International Journal of Molecular Sciences|August 19, 2020
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry DiseaseSanne J van der Veen, Wytze J Vlietstra, Laura van Dussen, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2004
Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretionKatarzyna Stolarz, Jan A Staessen, Kalina Kawecka-Jaszcz, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2014
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switchFrank Weidemann, Johannes Krämer, Thomas Duning, et al.
Pageof 13